NASDAQ:NRC National Research (NRC) Stock Price, News & Analysis $24.66 -0.55 (-2.18%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$24.39▼$25.6450-Day Range$22.09▼$31.3652-Week Range$21.73▼$47.25Volume98,525 shsAverage Volume89,386 shsMarket Capitalization$588.88 millionP/E Ratio19.89Dividend Yield1.95%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get National Research alerts: Email Address National Research MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy1.66% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.41Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.91 out of 5 starsBusiness Services Sector274th out of 317 stocksCommercial Physical Research Industry12th out of 12 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for National Research.Read more about National Research's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.66% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in National Research has recently increased by 8.64%, indicating that investor sentiment is decreasing significantly. Previous Next 1.7 Dividend Strength Dividend YieldNational Research pays a meaningful dividend of 1.93%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNational Research does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Research is 38.71%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about National Research's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NRC. Previous Next 1.9 News and Social Media Coverage News SentimentNational Research has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 4 news articles for National Research this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added National Research to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, National Research insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.00% of the stock of National Research is held by insiders.Percentage Held by Institutions47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about National Research's insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of National Research is 19.89, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.60.Price to Earnings Ratio vs. SectorThe P/E ratio of National Research is 19.89, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 22.19.Price to Book Value per Share RatioNational Research has a P/B Ratio of 12.21. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about National Research's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About National Research Stock (NASDAQ:NRC)National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.Read More NRC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NRC Stock News HeadlinesJuly 26 at 8:14 PM | finance.yahoo.comGovernment of Canada announces milestones for new science facilities in National Capital AreaJuly 20, 2024 | msn.comUS vows more robust support for Philippines nuclear developmentJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 19, 2024 | msn.comLeadership change won’t affect US-PH nuclear cooperation — US NRCMay 24, 2024 | msn.comTrudeau's promised made-in-Canada vaccine plant hasn't produced any shotsMay 24, 2024 | msn.comSC notice to government over Aadhaar cards on NRC listMay 13, 2024 | msn.comPhilippines realtors set national conventionMay 12, 2024 | finance.yahoo.comNational Research Corporation (NASDAQ:NRC) Q1 2024 Earnings Call TranscriptJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 11, 2024 | uk.investing.comEarnings call: National Research Corporation targets robust growth in 2024May 11, 2024 | finance.yahoo.comNational Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12May 10, 2024 | techcrunch.comHerbert LinMay 9, 2024 | finance.yahoo.comNational Research Corp (NRC) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth ...May 7, 2024 | finance.yahoo.comNational Research Corp (NRC) Reports Q1 2024 Financial ResultsMay 7, 2024 | markets.businessinsider.comNRC Stock Earnings: National Research Reported Results for Q1 2024May 7, 2024 | businesswire.comNational Research Corporation Announces First Quarter ResultsMay 6, 2024 | finanznachrichten.deLexaria Bioscience Corp.: Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 DrugsMay 2, 2024 | msn.comWaiting for Eritrean Human Traffickers' Trials in the NetherlandsSee More Headlines Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Ex-Dividend for 7/15 Dividend6/28/2024Dividend Payable7/15/2024Today7/26/2024Next Earnings (Estimated)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Commercial physical research Sub-IndustryN/A Current SymbolNASDAQ:NRC CUSIPN/A CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees435Year Founded1981Profitability EPS (Most Recent Fiscal Year)$1.24 Trailing P/E Ratio19.90 Forward P/E RatioN/A P/E GrowthN/ANet Income$30.97 million Net Margins20.60% Pretax Margin26.55% Return on Equity54.83% Return on Assets24.43% Debt Debt-to-Equity Ratio0.75 Current Ratio0.41 Quick Ratio0.41 Sales & Book Value Annual Sales$148.58 million Price / Sales3.96 Cash Flow$1.51 per share Price / Cash Flow16.37 Book Value$2.02 per share Price / Book12.21Miscellaneous Outstanding Shares23,880,000Free Float23,399,000Market Cap$589.12 million OptionableOptionable Beta0.50 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Michael D. Hays (Age 69)Founder, CEO, President & Director Comp: $131.11kMs. Helen L. Hrdy (Age 59)Chief Customer Officer Comp: $291.51kMr. Christophe Louvion (Age 51)Chief Product & Technology Officer Mr. Andy Monnich (Age 48)Chief Corporate Development Officer Mr. Jon BoumsteinChief Delivery OfficerDr. Gregory Makoul M.S.Ph.D., Chief Transformation OfficerMr. Jason Hahn (Age 52)Chief Revenue Officer Ms. Linda StacySecretaryMegan CharkoSenior Manager of Content MarketingMore ExecutivesKey CompetitorsOmniAbNASDAQ:OABIAbsciNASDAQ:ABSIMaxCyteNASDAQ:MXCTPrecigenNASDAQ:PGENLuna InnovationsNASDAQ:LUNAView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 6,295 shares on 7/26/2024Ownership: 0.516%Conestoga Capital Advisors LLCSold 737,001 shares on 7/26/2024Ownership: 0.200%Summit Global InvestmentsBought 2,683 shares on 7/22/2024Ownership: 0.062%QV Investors Inc.Sold 3,870 shares on 7/16/2024Ownership: 1.417%CWM LLCBought 1,041 shares on 7/10/2024Ownership: 0.005%View All Insider TransactionsView All Institutional Transactions NRC Stock Analysis - Frequently Asked Questions How have NRC shares performed this year? National Research's stock was trading at $39.56 at the start of the year. Since then, NRC stock has decreased by 37.7% and is now trading at $24.66. View the best growth stocks for 2024 here. How were National Research's earnings last quarter? National Research Co. (NASDAQ:NRC) issued its quarterly earnings data on Tuesday, May, 7th. The company reported $0.27 EPS for the quarter. The company had revenue of $35.31 million for the quarter. National Research had a trailing twelve-month return on equity of 54.83% and a net margin of 20.60%. What is Michael D. Hays' approval rating as National Research's CEO? 85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees. Does National Research have any subsidiaries? National Research subsidiaries include PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada. Who are National Research's major shareholders? National Research's top institutional shareholders include QV Investors Inc. (1.42%), Bank of New York Mellon Corp (0.52%), Conestoga Capital Advisors LLC (0.20%) and Summit Global Investments (0.06%). Insiders that own company stock include Amandla Mk Trust, Kevin R Karas and Jona S Raasch. View institutional ownership trends. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE) and Toronto-Dominion Bank (TD). This page (NASDAQ:NRC) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.